1 – 10 of 13
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
Social, cultural and economic aspects of antimicrobial resistance
(
- Contribution to journal › Article
-
Mark
When does stand-alone software qualify as a medical device in the European Union?: The CJEU decision in SNITEM and what it implies for the next generation of medical devices
(
- Contribution to journal › Article
- 2018
-
Mark
Reap what you sow! - But what about SPC squatting?
(
- Contribution to journal › Article
- 2017
-
Mark
Patenting Human Genes in Europe: and how it compares to the US and Australia
(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Innovation and Intellectual Property Policies in European Research Infrastructure Consortia - PART I: The Case of the European Spallation Source ERIC
(
- Contribution to journal › Article
- 2016
-
Mark
Fighting Falsified Medicines with Paperwork – A Historic Review of Danish Legislation Governing Distribution of Medicines
(
- Contribution to journal › Article
-
Mark
Reconciling IPRs and openness in biobanking
(
- Contribution to journal › Article
-
Mark
Standards, Data Exchange and Intellectual Property Rights in Systems Biology
(
- Contribution to journal › Article
-
Mark
The Industrial Application Requirement for Biotech Inventions in Light of Recent EPO and UK Case Law: A Plausible Approach or a Mere "Hunting Licence"?
(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2015
-
Mark
The Evolution of the CJEU’s Case Law on Stem Cell Patents : Context, Outcome and Implications of Case C‑364/13 International Stem Cell Corporation
(
- Contribution to journal › Article